You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

January 8, 2018

APFI Food Safety Regulations Series: Thailand

Asia Pacific Food Industry (APFI)

To better understand the food regulatory landscape in Asia, APFI has spoken to law firms that specialize in food law from five different countries across Asia, which include China, Thailand, Vietnam, Singapore and the Philippines.

In the second part of the series, we look at food safety regulations in Thailand. Alan Adcock, partner and deputy director, intellectual property and regulatory affairs, Tilleke & Gibbins, shares his advice.

How do food regulation and registration vary depending on the product or category?

The Thailand FDA classifies food products into four groups, depending on the risk level of the food, as follows:

1. Specially controlled food: The foods in this group have a high risk level. This food group defines all quality standards, including labelling and production processes, and is tightly controlled. It includes foods for consumer risk groups such as infants.

The foods in this group are modified infant milk and modified infant milk formula, infant food and infant food formula, supplementary food for infants and young children, weight-control food, food additives, cyclamates, and steviol glycosides.

2. Standardized food: This group comprises foods with a medium risk level. There are quality and labelling standards for each category of food, as in the first group. However, product owners are directly responsible for ensuring their products are in accordance with FDA regulations (i.e., regulations on formula, labelling, and safety and quality standards).

The foods in this group are coffee, edible salt, vitamin-fortified rice, alkaline-preserved egg, cream, electrolyte drinks, chocolate, tea, herbal tea, a few kinds of sauces (i.e., tomato sauce, chili sauce, papaya sauce, and flour sauce), ice, soy milk, drinking water, fish sauce, honey, peanut oil, butter oil, palm oil, coconut oil, fats and oils, mineral water, vinegar, butter, cheese, ghee, margarine and fat spreads, soy sauce, jam, jelly and marmalade, semi processed food, brine for cooking, royal jelly, royal jelly products, food supplements, beverages, cow’s milk, flavored milk, milk products, yoghurt, ice cream, and food in sealed containers.

Royal jelly products, food supplements, beverages, cow’s milk, flavored milk, milk products, yoghurt, ice cream, and food in sealed containers are tightly controlled.

3. Food with labelling: This group comprises foods with a medium risk level. The FDA was formerly responsible for approving the labelling of food in this group. Currently, this group is no different from the second group. Product owners are directly responsible for ensuring their products are in accordance with FDA regulations (i.e., regulations on formula, labelling, safety, and quality standards).

The foods in this group are bread, husked-rice flour, sauces, meat products, flavoring, gelatine and jelly desserts, chewing gum and candy, ready-to-cook and ready-to-eat products, irradiated foods, GMO foods, and specially purposed food.

Specially purposed food (e.g., medical food, food for special persons, etc.) is tightly controlled.

4. General food: This group comprises foods with a low risk level. Foods in this group do not require food product registration with the FDA.

The foods in this group are animals and animal products, plants and plant products, extracts or synthetic substances, nutrients, flour and flour products, premixed food for ready-to-cook products, seasoning, sugar, and spices.

In addition, the Thailand FDA provides basic levels of food safety that food manufacturing companies must adhere to in the form of ‘good manufacturing practices’ issued as notifications by the Ministry of Public Health. These are mandatory and discrete to certain food products. It is important for manufacturers to check regularly whether any are applicable to their products.

Have you seen a growth in the number of food and beverage companies entering the markets in Thailand?

We have seen growth not only in Thailand but also across the growing economies of Southeast Asia. Many clients encouraged us to expand our legal and regulatory services to other jurisdictions in the Association of Southeast Asian Nations, which we did in 2013 by opening our own fully independent law offices in Indonesia, Laos and Myanmar and subsequently in 2015 in Cambodia.

We find that more and more of our clients are looking for a ‘one-stop shop’ that can, for example, handle registration of their highly regulated products in multiple jurisdictions, which we provide with our cross-office Regulatory Affairs practice. We are also seeing more foreign clients pursuing patent litigation cases as local laws get tougher.

Food supplements and nutraceuticals are also becoming more prevalent in Southeast Asian markets. Interestingly, there is a growing number of local and foreign collaborative research and development projects focusing on indigenous flora for possible food and cosmetic applications.

We have seen a marked increase in the number of these projects across our offices here in Southeast Asia and we advise on the agreements, benefit-sharing assessments with local communities, plant variety and patent assessment and registration and, of course, manufacturing and distribution.

Which regulatory hurdles should manufacturers be aware of when entering the food market in Thailand?

Non-English language regulations require constant monitoring and vetting for importance to clients. Our regular involvement in local domestic industry associations also gives us opportunity to participate in regulatory drafting, consultation and bringing client perspectives to the attention of the regulators.

Regulatory non-compliance can result in fines and/or imprisonment depending on the violation and the type of product involved.

Will there be any major changes in Thailand’s food industry in the next few years?

The Thai legislative agenda can be difficult to predict, due to the changeable nature of Thai politics. However, the current government has been very enthusiastic about promoting the food industry as a driver of economic growth, and has made particular efforts to encourage startups in the industry.

In mid-2016, the government announced the establishment of a National Science Technology and Innovation Policy Office, which launched the Food Innopolis initiative. The initiative comprises a specifically designed science park, at which research and development companies can benefit from substantial tax incentives and various other forms of government support, many of which are guaranteed for between five and eight years.

This is indicative of a number of policies which the government has been seen to support, and it is reasonable to assume that the result will be a substantial increase in technologically innovative food and agricultural startups in the coming decade.

Please give a description of the firm.

Tilleke & Gibbins is a regional law firm in Southeast Asia, with 150 lawyers and consultants in Bangkok, Hanoi, Ho Chi Minh City, Jakarta, Phnom Penh, Vientiane, and Yangon. We represent investors and companies in the key areas of commercial transactions as well as mergers and acquisitions, dispute resolution and litigation, and intellectual property.

One of our important practice areas is regulatory affairs, where we assist companies in the pharmaceutical, cosmetics, consumer products, food and beverages, biotech, medical devices, veterinary products, and other life sciences sectors to enter markets throughout Southeast Asia. We assist companies in research and development and clinical trials to registration and market entry to commercialization and technology transfer, through every stage of a product’s life cycle.

Our regulatory affairs practice spans the following disciplines:

  • Clinical Trials and Consumer Testing
  • Food and Drug Administration (FDA) Registration
  • FDA Import, Export, and Manufacturing Licenses
  • Ministry of Agriculture (MOA) Crop Care Registration
  • MOA Animal, Aquatic, and Hazardous Substance Registration
  • MOA Import, Export, and Manufacturing Licenses
  • Holding Licenses
  • Regulatory Compliance and Maintenance
  • Labelling and Advertising Clearance
  • Intellectual Property

 Article by Farah Nazurah. Source: http://apfoodonline.com/industry/food-safety-regulations-series-vietnam/

 

RELATED INSIGHTS​ 

September 9, 2026
On August 5, 2026, the Consumer Case Division of Thailand’s Civil Court rendered a judgment in a case involving a beauty clinic that advertised acne scar treatments using claims that the clinic was operated by a specialist physician and that the treatment, allegedly involving stem cell technology, could permanently remove acne scars. The plaintiff brought a claim against both the physician-owner and the clinic company, alleging that the advertisements were false and induced her to purchase the treatment. The court found that the clinic was liable for the false representations and that the physician-owner, as both the authorized director of the company and the medical practitioner who provided treatment, was jointly responsible. Although the plaintiff could not fully prove all damages claimed, the court awarded compensation of THB 20,000, together with interest. While the judgment arose from a consumer protection dispute, it serves as a valuable reminder that medical facility advertisements in Thailand are regulated and may expose clinics and healthcare providers not only to regulatory enforcement but also to civil liability from patients who rely on misleading promotional claims. Regulatory Framework Governing Medical Facility Advertisements Medical facility advertising in Thailand is governed by the Medical Facility Act B.E. 2541 (1998), as amended by the Medical Facility Act (No. 4) B.E. 2559 (2016). The principal secondary legislation is the Department of Health Service Support (DoHSS) Notification Re: Rules, Procedures, Conditions, and Fees for an Advertisement or Publication Concerning a Medical Facility, which came into force on November 25, 2019. Under this notification, “advertising” includes any act, by any means, that causes members of the public to see, hear, or otherwise become aware of a message, sound, or image for the commercial benefit of a medical facility. This broad definition covers not only traditional media but also clinic websites, social
September 9, 2026
On June 30, 2026, Indonesia’s National Agency of Drug and Food Control (BPOM) issued BPOM Regulation No. 11 of 2026 on Food Packaging, which expands the list of approved food-contact substances and recognizes a broader range of permissible functions for those substances. The new regulation, which revokes BPOM Regulation No. 20 of 2019, reflects developments in packaging technology and materials science. Although the new regulation provides more advantages to business actors by adding more food contact substances to the approved list for use in food packaging, there are more stringent rules and restrictions for testing. One of the most significant changes is a comprehensive migration-testing framework that sets out requirements for packaging materials, testing conditions, food simulants, and specific migration limits. Overall and Specific Migration Under BPOM Regulation No. 20 of 2019, migration requirements were primarily set out within the lists of approved food-contact substances and packaging materials. BPOM Regulation No. 11 of 2026 instead expressly requires packaging materials that come into direct contact with food to meet both overall and specific migration limits. These are defined as follows: Overall migration: The total quantity of all substances that migrate from the packaging, regardless of whether the substances are hazardous or nonhazardous to health. Specific migration: The quantity of a particular identified substance known to be hazardous to health that migrates from the packaging. Stricter Limits on Heavy Metals The overall migration limit for plastic packaging remains unchanged under both regulations at 60 mg/kg or 10 mg/dm². However, the new regulation introduces significant changes to the regulation of heavy metals. Under the 2019 regulation, four heavy metals—lead, cadmium, chromium VI, and mercury—were subject to a single combined limit of 1 mg/kg. The 2026 regulation, however, requires each heavy metal to meet its own individual specific migration limit, adds arsenic as
September 7, 2026
Indonesia’s Constitutional Court (Mahkamah Konstitusi) has reinstated a key provision limiting pharmaceutical patent protection, signaling a renewed commitment to balancing patent rights with public access to medicines. In its ruling to Case No. 255/PUU-XXIII/2025, the court partially granted a petition for judicial review of Law No. 65 of 2024, which had amended the country’s Patent Law, and ordered the restoration of a provision that had excluded certain pharmaceutical inventions from patentability. The decision took effect immediately upon its pronouncement at the court’s plenary session on August 28, 2026. Background The petition challenged the removal of article 4(f) from Law No. 13 of 2016 concerning Patents (Patent Law), as amended by Law No. 65 of 2024. Article 4(f) had excluded from patentability certain inventions relating to new uses of known substances. The petitioners argued that removing this provision would open the door to patent protection for second medical use inventions and facilitate patent evergreening—practices that can extend exclusivity periods, delay generic market entry, and reduce public access to affordable medicines. The petitioners included several patient advocacy and public-interest organizations: the Indonesian Dialysis Patients Community Association, the Indonesian Association of Drug Abuse Victims (PKNI), the Indonesian Pulmonary Hypertension Foundation (YHPI), the Rekat Peduli Indonesia Foundation, and the Indonesian Positive Women’s Association (IPPI), along with the Indonesia for Global Justice Association and four individual petitioners. The petitioners also challenged the constitutionality of the phrase “interested party” in article 70(1) of the Patent Law, arguing that it should be construed expressly to clarify who has standing to appeal a decision to grant a patent before the Board of Patent Appeal, and to allow a broader range of parties—such as patent holders, licensees, consumer organizations, prosecutors, aggrieved third parties, and others who may suffer direct or indirect harm from the grant of a patent—to
September 4, 2026
Blind boxes and collectibles have become increasingly popular, driven by the excitement of not knowing which character or design will be revealed until the package is opened. While most visible in the art toy market, the same concept is also used in the food industry. Confectionery, snacks, and other food products are sometimes sold with toys, character figures, cards, or other collectibles. A package might, for example, contain one of ten possible characters, with consumers knowing that an item is included but not which one they will receive. Some collections may also feature rare or “secret” items. For food businesses, however, adding a randomized toy or collectible involves more than a marketing decision. The food, the nonfood item, and the randomized mechanism may each raise different regulatory considerations in Thailand. Thai FDA Requirements for Nonfood Objects Packaged with Food The main food regulatory consideration is Ministry of Public Health Notification No. 310 B.E. 2551 (2008), which regulates food packaged together with things or objects that are not food. Under Notification No. 310, certain nonfood objects may be packaged together with food where they fall within specified exceptions, including objects that serve the following purposes: Maintaining the quality or standard of the food, such as a desiccant or oxygen absorber; Serving as a seasoning or as part of food preparation, such as chili powder sachets or seasoning sachets contained in instant noodle packages; or Functioning as an eating or food-preparation utensil, such as a spoon or fork included with instant noodles. Other nonfood objects that do not fall within these categories generally should not be placed inside the food container together with the food. Where a toy, collectible, or other nonfood object is intended to be sold together with a food product, businesses should therefore carefully consider the nature of